ANTI-CORONAVIRUS ANTIBODIES AND METHODS OF USE

Antibodies that bind SARS-CoV Spike protein, SARS-CoV-2 Spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2. L'invention concerne des anticorps qui se lient à la protéine de spicule du SRAS-CoV...

Full description

Saved in:
Bibliographic Details
Main Authors GOPALRATHNAM, Ganapathy, ABIONA, Olubukola, KONG, Wing-pui, CORBETT, Kizzmekia, BOYLES, Jeffrey Streetman, LEDGERWOOD, Julie, CHAI, Qing, HENDLE, Jörg, MASCOLA, John, PUSTILNIK, Anna, JEPSON, Kevin, ZHANG, Yi, SHI, Wei, WESTENDORF, Kathryn, GRAHAM, Barney, JONES, Bryan Edward, DAVIES, Julian, MUTHURAMAN, Krithika, SAUDER, John Michael, FALCONER, Ester, ZENTELIS, Stefanie, WANG, Lingshu, FRYE, Christopher Carl, FOSTER, Denisa
Format Patent
LanguageEnglish
French
Published 16.09.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Antibodies that bind SARS-CoV Spike protein, SARS-CoV-2 Spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2. L'invention concerne des anticorps qui se lient à la protéine de spicule du SRAS-CoV et à la protéine de spicule du SRAS-CoV-2, et des méthodes d'utilisation de ceux-ci pour traiter ou prévenir des états associés au SRAS ou à la COVID-19 et pour détecter le SRAS-CoV ou le SRAS-CoV-2.
Bibliography:Application Number: WO2021US20843